OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting neuroinflammation by intranasal delivery of nanoparticles in neurological diseases: a comprehensive review
Fatemeh Moradi, Nasrin Dashti
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 2, pp. 133-148
Closed Access | Times Cited: 21

Showing 21 citing articles:

Nanoparticle-Based Drug Delivery Systems: An Inspiring Therapeutic Strategy for Neurodegenerative Diseases
Linyan Duan, Xingfan Li, Rong Ji, et al.
Polymers (2023) Vol. 15, Iss. 9, pp. 2196-2196
Open Access | Times Cited: 40

Synthesis of a Rivastigmine and Insulin Combinational Mucoadhesive Nanoparticle for Intranasal Delivery
Tahereh Jamshidnejad-Tosaramandani, Soheila Kashanian, Isaac Karimi, et al.
Polymers (2024) Vol. 16, Iss. 4, pp. 510-510
Open Access | Times Cited: 13

Strategies to Enhance Nanocrystal Formulations for Overcoming Physiological Barriers Across Diverse Routes of Administration
Yaswanthi Yanamadala, Chandra Mohan Reddy Muthumula, Sangeeta Khare, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 367-402
Open Access | Times Cited: 1

Natural drug delivery systems for the treatment of neurodegenerative diseases
Greta Kaspute, Arūnas Ramanavičius, Urtė Prentice
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1

Synthesis of an insulin-loaded mucoadhesive nanoparticle designed for intranasal administration: focus on new diffusion media
Tahereh Jamshidnejad-Tosaramandani, Soheila Kashanian, Isaac Karimi, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14

Curcumin/TGF-β1 siRNA loaded solid lipid nanoparticles alleviate cerebral injury after intracerebral hemorrhage by transnasal brain targeting
Munire Abudurexiti, Jun Xue, Xianzhe Li, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 237, pp. 113857-113857
Open Access | Times Cited: 5

Rational design of siRNA-based delivery systems for effective treatment of brain diseases
Dailin Lu, Yonghang Sun, Yuxia Luan, et al.
Pharmaceutical Science Advances (2024) Vol. 2, pp. 100041-100041
Open Access | Times Cited: 5

Positive Effects of Seabuckthorn oil on Scopolamine Induced PC12 Cell Damage and APP/PS1 Mice
Dongliang Yang, Song Zhang, Duo Wang, et al.
Natural Product Communications (2025) Vol. 20, Iss. 3
Open Access

Effects of graphene oxide nanoparticles administration against reserpine-induced neurobehavioral damage and oxidative stress in an animal model of Parkinson's disease
Mjid Oukhrib, Lahcen Tamegart, Abdeslam Assafi, et al.
Food and Chemical Toxicology (2023) Vol. 178, pp. 113904-113904
Closed Access | Times Cited: 7

Intranasal Delivery of Sulpiride Nanostructured Lipid Carrier to Central Nervous System; In Vitro Characterization and In Vivo Study
Hesham M. Tawfeek, Aml I. Mekkawy, Ahmed A.H. Abdelatif, et al.
Pharmaceutical Development and Technology (2024), pp. 1-25
Closed Access | Times Cited: 2

Enhancing Acute Migraine Treatment: Exploring Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for the Nose-to-Brain Route
Joana Torres, Renata Silva, Gonçalo Farias, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1297-1297
Open Access | Times Cited: 2

Nucleic acid-based therapeutics for the treatment of central nervous system disorders
Robyn McCartan, Olga Khorkova, Claude‐Henry Volmar, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 6

Intranasal delivery of Chitosan-based nanoparticles as an innovative way for management of neurodegenerative disorders: a comprehensive review of advanced strategies for CNS targeting
Rabab M. Ibrahim, Mahmoud H. Teaima, Mohamed A. El-Nabarawi, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 105885-105885
Closed Access | Times Cited: 1

A Comprehensive Review on Nanomedicine: Promising Approach for Treatment of Brain Tumor through Intranasal Administration
Shiv Bahadur, Anubhav Prakash
Current Drug Targets (2022) Vol. 24, Iss. 1, pp. 71-88
Closed Access | Times Cited: 4

Oncostatin M: a love-hate relationship in neuroinflammation
Doryssa Hermans, Niels Hellings, Bieke Broux
Neural Regeneration Research (2024) Vol. 19, Iss. 12, pp. 2571-2572
Open Access

Insights in RNA: 2022
Yadong Zheng, Rui Li, William C. Cho, et al.
Frontiers research topics (2024)
Open Access

Nose-to-Brain Delivery of Nanoformulations for Treatment of Depression
Tahmineh Mokhtari, Fatemeh Sheikhbahaei, Maryam Saadat, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 245-274
Closed Access

Surface-engineered quantum dot nanocomposites for neurodegenerative disorder remediation and avenue for neuroimaging
Muhanna K. Al‐Muhanna, Amani Alghamdi, Bahauddeen M. Alrfaei, et al.
Nanotechnology Reviews (2024) Vol. 13, Iss. 1
Open Access

Nanoneuroscience: Cutting-edge Approach for Disease Management
Sakshi Malhotra, Neha Jain, Jatin Rathee, et al.
Recent Patents on Nanotechnology (2023) Vol. 18, Iss. 3, pp. 305-320
Closed Access | Times Cited: 1

Page 1

Scroll to top